comorbidities for glp 1 GLP-1 Agonists Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Why are GLP-1 agonists being

Limited access moving forward If you rely on compounded semaglutide, your medication may soon be unavailable, requiring a shift to FDA-approved options

Pharmaceutical giants continue expanding indications, ensuring ongoing relevance in diabetes care

Eating less should help

New and expanded recommendations include: Annual screening for anxiety and diabetes distress Referral when distress exceeds what the visit can address Routine screening for sleep health Avoidance of tobacco and vaping with combined counseling and pharmacotherapy These updates acknowledge that physiology responds to behavior, sleep, and mental health

Recovery Amenities Recovery is an important part of any wellness plan